Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

Functional Imaging to Differentiate Pulmonary Carcinoids

Tarun Jindal, Arvind Kumar, Rakesh Kumar and Roman Dutta
Journal of Nuclear Medicine September 2010, 51 (9) 1488; DOI: https://doi.org/10.2967/jnumed.110.077826
Tarun Jindal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arvind Kumar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakesh Kumar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roman Dutta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: We read with great interest the article by Kayani et al. (1). They evaluated 11 cases of typical carcinoids, 2 of atypical carcinoids, 1 of small cell neuroendocrine tumor, 1 of large cell neuroendocrine tumor, 2 of diffuse idiopathic pulmonary neuroendocrine hyperplasia, and 1 of adenocarcinoma with neuroendocrine differentiation using 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT. They reported that, compared with typical carcinoids, atypical and other less differentiated carcinoids revealed significantly higher uptake on 18F-FDG PET/CT scans (P = 0.005) and significantly lower uptake on 68Ga-DOTATATE PET/CT scans (P = 0.002).

We observed an interesting finding by evaluating the ratios of maximum standardized uptake value (SUVmax) on 68Ga-DOTATATE PET/CT to SUVmax on 18F-FDG PET/CT scans. The ratios range from 1.2 to 19.5 in typical carcinoids (median SUVmax, 7.3) but from 0.1 to 1.1 in other less differentiated carcinoids (median SUVmax, 0.16). This difference in the ratios of typical versus atypical and other less differentiated carcinoids is statistically significant. The P value is 0.002 (Mann–Whitney test for nonparametric data, 2-tailed). Thus, the ratio of SUVmax on 68Ga-DOTATOC PET/CT and 18F-FDG PET/CT may also be of help in predicting the histopathologic variety of the carcinoid tumor and may have an equally high accuracy. A larger study is indicated to validate this observation and to objectively determine a cutoff value for the possible differentiation.

  • © 2010 by Society of Nuclear Medicine

REFERENCE

  1. 1.↵
    1. Kayani I,
    2. Conry BG,
    3. Groves AM,
    4. et al
    . A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors. J Nucl Med. 2009;50:1927–1932.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (9)
Journal of Nuclear Medicine
Vol. 51, Issue 9
September 1, 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Functional Imaging to Differentiate Pulmonary Carcinoids
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Functional Imaging to Differentiate Pulmonary Carcinoids
Tarun Jindal, Arvind Kumar, Rakesh Kumar, Roman Dutta
Journal of Nuclear Medicine Sep 2010, 51 (9) 1488; DOI: 10.2967/jnumed.110.077826

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Functional Imaging to Differentiate Pulmonary Carcinoids
Tarun Jindal, Arvind Kumar, Rakesh Kumar, Roman Dutta
Journal of Nuclear Medicine Sep 2010, 51 (9) 1488; DOI: 10.2967/jnumed.110.077826
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCE
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Reply to “The Randomized, Phase 2 LuCAP Study”
  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire